CMI Communications

22/02/2026

🎙️ Just published Communicable E47: Drawing the line: the writing, reach and limits of guidelines
Hosted by Angela Huttner & Erin McCreary w/ invited guests Pranita Tamma (USA) & Benedikt Huttner (Switzerland)

Listen on : https://share.transistor.fm/s/a0513ed3

19/02/2026

In this 3rd collaboration between SIDP Breakpoints & ESCMID’s Communicable, Erin McCreary & Angela Huttner host Pranita Tamma (USA) & Benedikt Huttner (WHO, Switzerland) to discuss & guidance, offering a behind-the-scenes look into their development, reach - and limits.

12/02/2026

📣 What is a ?

It's something you should probably use for culture-negative prosthetic joint infections. Local antibiograms alone can be misleading.

This WISCA showed that doxycycline + a fluoroquinolone offer best coverage for

Prosthetic joint infections (PJIs) are now routinely treated with oral antibiotics, but selecting empiric regimens is challenging, including for treat…

08/02/2026

🎙️ Just published Communicable E46: Steroids for pneumocystis pneumonia

Hosted by Nav Narayanan & Josh Nosanchuk

w/ invited guests Virginie Lemiale, Elie Azoulay & Emily McDonald

Listen on : https://share.transistor.fm/s/0066901c

05/02/2026

📣 New drops Mon 9 Feb! Nav Narayanan & Josh Nosanchuk host Virginie Lemiale and Elie Azoulay, who led the PIC trial, and Emily McDonald to discuss the utility of adjunctive steroid therapy for pneumocystosis in HIV- individuals. Tune in Monday 🎙️

30/01/2026

✨ The journal is happy to introduce its new associate editor, Anne-Grete Märtson, who leads the Antiviral Pharmacology research group at Leiden University.

Congratulations and welcome! We are so happy to have you on board!

29/01/2026

📣 Foley et al assess PCR & serology in >8K Australian patients

: still essential for first infections & reinfections

: limited add'l benefit in first infections; w/ serology can improve detection of reinfections

Syphilis has re-emerged as a global public health concern. Although serology is well established, the role of PCR remains unclear. We evaluated the di…

25/01/2026

🎙️ Just published Communicable E45: Top infectious diseases papers in 2025

Hosted by Josh Davis & Emily McDonald w/ invited guest Steven Tong

Listen on : https://share.transistor.fm/s/9e626f2a

In this episode of Communicable, Josh Davis (Newcastle, Australia) and Emily McDonald (Montreal, Canada), plus invited guest, Steven Tong (Melbourne, Australia)—all practicing physicians and clinical trialists—assemble to discuss some of their ‘top infectious diseases papers published in 2025....

22/01/2026

📣 New drops Mon 26 Jan! In our last episode, we brought you some favorite papers of 2025. We continue this thread in our next episode with top ID papers of 2025, picked by our editors, Josh Davis & Emily McDonald, and guest, Steven Tong. ⭐ Tune in Monday🎙️

20/01/2026

📣 A peer reviewer used to create a fake review with 6 self-citation prompts. But is s/he the only perpetrator in our system? In the year's first editorial, Angela Huttner explores the depths of the academic-industrial complex.

CMI CommunicationsAvailable online 14 January 2026, 105173In Press, Journal Pre-proofWhat’s this?EditorialThe beating heart of a broken machineAuthor links open overlay panelAngela HuttnerShow moreAdd to MendeleyShareCitehttps://doi.org/10.1016/j.cmicom.2026.105173Get rights and contentUnder a Cre...

15/01/2026

📣 Are steroids likely to reduce mortality in non-HIV patients with severe P*P?
Lee TC, McDonald EG, et al. reexamine the Lemiale RCT with a Bayesian lens to find out.

https://www.cmi-comms.org/article/S2950-5909(25)00082-4/fulltext

14/01/2026

📣 Systematic review by Cordes L, Trautner BW, Lambregts M, et al assessing evidence for long durations in chronic bacterial . Spoiler: there isn’t much.

https://www.cmi-comms.org/article/S2950-5909(25)00097-6/fulltext